Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Negroni

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Proteomes|January 22, 2024
How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?Paul Dowling, Capucine Trollet, Elisa Negroni, et al.
Frontiers in Physiology|October 30, 2014
Altered cross-bridge properties in skeletal muscle dystrophiesAziz Guellich, Elisa Negroni, Valérie Decostre, et al.
Frontiers in Genetics|April 26, 2018
Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment EfficacyGonzalo Cordova, Elisa Negroni, Claudio Cabello-Verrugio, et al.
Human Gene Therapy|December 15, 2015
Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical SuccessesElisa Negroni, Anne Bigot, Gillian S Butler-Browne, et al.
European Journal of Translational Myology|May 29, 2025
Serum protein biomarker signature of Duchenne muscular dystrophyPaul Dowling, Elisa Negroni, Capucine Trollet, et al.
Expert Review of Proteomics|May 16, 2024
The potential of proteomics for in-depth bioanalytical investigations of satellite cell function in applied myologyPaul Dowling, Capucine Trollet, Laura Muraine, et al.
Neuropathology and Applied Neurobiology|November 19, 2014
Invited review: Stem cells and muscle diseases: advances in cell therapy strategiesElisa Negroni, Teresa Gidaro, Anne Bigot, et al.
Proteomics|November 11, 2025
Proteomic Profiling of Myofiber Repair Annexins and Their Role in Duchenne Muscular DystrophyPaul Dowling, Dounia Bouragba, Elisa Negroni, et al.
Expert Review of Proteomics|May 4, 2026
Potential proteomic biomarkers for monitoring clinical studies in Duchenne/Becker muscular dystrophyPaul Dowling, Dounia Bouragba, Elisa Negroni, et al.
Expert Opinion on Biological Therapy|January 12, 2011
Current advances in cell therapy strategies for muscular dystrophiesElisa Negroni, Denis Vallese, Jean-Thomas Vilquin, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Proteomes|January 22, 2024
How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?Paul Dowling, Capucine Trollet, Elisa Negroni, et al.
Frontiers in Physiology|October 30, 2014
Altered cross-bridge properties in skeletal muscle dystrophiesAziz Guellich, Elisa Negroni, Valérie Decostre, et al.
Frontiers in Genetics|April 26, 2018
Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment EfficacyGonzalo Cordova, Elisa Negroni, Claudio Cabello-Verrugio, et al.
Human Gene Therapy|December 15, 2015
Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical SuccessesElisa Negroni, Anne Bigot, Gillian S Butler-Browne, et al.
European Journal of Translational Myology|May 29, 2025
Serum protein biomarker signature of Duchenne muscular dystrophyPaul Dowling, Elisa Negroni, Capucine Trollet, et al.
Expert Review of Proteomics|May 16, 2024
The potential of proteomics for in-depth bioanalytical investigations of satellite cell function in applied myologyPaul Dowling, Capucine Trollet, Laura Muraine, et al.
Neuropathology and Applied Neurobiology|November 19, 2014
Invited review: Stem cells and muscle diseases: advances in cell therapy strategiesElisa Negroni, Teresa Gidaro, Anne Bigot, et al.
Proteomics|November 11, 2025
Proteomic Profiling of Myofiber Repair Annexins and Their Role in Duchenne Muscular DystrophyPaul Dowling, Dounia Bouragba, Elisa Negroni, et al.
Expert Review of Proteomics|May 4, 2026
Potential proteomic biomarkers for monitoring clinical studies in Duchenne/Becker muscular dystrophyPaul Dowling, Dounia Bouragba, Elisa Negroni, et al.
Expert Opinion on Biological Therapy|January 12, 2011
Current advances in cell therapy strategies for muscular dystrophiesElisa Negroni, Denis Vallese, Jean-Thomas Vilquin, et al.
Pageof 5